{"retracted":false,"update":{"timestamp":1216684800000,"doi":"10.1212/01.wnl.0000326569.90542.da","type":"correction"},"doi":"10.1212/01.wnl.0000313837.45525.b6","journal":"Neurology","publisher":"Ovid Technologies (Wolters Kluwer Health)","title":"Neurologic consequences of autoimmune polyglandular syndrome type 1"}
